Highlights
Across Sweden and France, prevalence increased significantly from 2003 to 2022 for Parkinson disease (PD), multiple sclerosis (MS), and motor neuron diseases (MNDs), but the underlying drivers differed by disease.
For MS, rising prevalence appears to be driven largely by improved survival after diagnosis rather than a substantial increase in incidence.
